Literature DB >> 15258079

Sentinel lymph node biopsy: not yet standard of care for melanoma.

J Meirion Thomas, Matthew A Clark.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15258079      PMCID: PMC478238          DOI: 10.1136/bmj.329.7458.170

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  5 in total

1.  U.K. guidelines for the management of cutaneous melanoma.

Authors:  D L L Roberts; A V Anstey; R J Barlow; N H Cox; J A Newton Bishop; P G Corrie; J Evans; M E Gore; P N Hall; N Kirkham
Journal:  Br J Dermatol       Date:  2002-01       Impact factor: 9.302

2.  Sentinel lymph node biopsy.

Authors:  Malcolm R Kell; Michael J Kerin
Journal:  BMJ       Date:  2004-06-05

Review 3.  Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.

Authors:  J M Thomas; M A Clark
Journal:  Eur J Surg Oncol       Date:  2004-08       Impact factor: 4.424

4.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group.

Authors:  D L Morton; J F Thompson; R Essner; R Elashoff; S L Stern; O E Nieweg; D F Roses; C P Karakousis; N Mozzillo; D Reintgen; H J Wang; E C Glass; A J Cochran
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

5.  Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials.

Authors:  Keith Wheatley; Natalie Ives; Barry Hancock; Martin Gore; Alexander Eggermont; Stefan Suciu
Journal:  Cancer Treat Rev       Date:  2003-08       Impact factor: 12.111

  5 in total
  1 in total

1.  Completion lymphadenectomy may not increase in-transit disease in malignant melanoma.

Authors:  Robin Russell-Jones; Ciaran Healy; Ann-Marie Powell; Katharine Acland; Michael O'Doherty; Eduardo Calonje
Journal:  BMJ       Date:  2004-11-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.